What Causes a Shingles Outbreak?

Shingles is a painful disease that is caused by the same herpes virus that causes the chicken pox—the varicella zoster virus.

As herpes viruses go, it is very typical in its pathology. The varicella zoster virus has an initial infectious stage, which is the chicken pox, followed by a dormant stage, and then another active stage.

Estimates suggest about one in five people who had the chicken pox will develop shingles, but the issue becomes pertinent here when a person's immune system is compromised, as can be the case from anti-lymphoma treatments, including monoclonal antibodies such as rituximab. In those instances reactivation of the virus becomes much more common and likely.

The virus lives within nerve tissue, and during an outbreak the inflamed nerves will create itchiness, numbness, and pain on the skin area above the inflamed nerve.

Shingles Outbreaks From Lymphoma

Since lymphoma is a cancer of the lymphocytes, therefore affecting the patient's immune system, people with lymphoma as well as those receiving anticancer treatments for lymphoma are especially susceptible to reactivation of the virus because there is suddenly very little resistance meeting and containing it.

The same is true for organ transplant patients—any situation, in sum, that suppresses the immune system can create an opportunity for the virus to reactivate.

While there is a shingles vaccination available, the U.S. Centers for Disease Control have traditionally urged people with lymphoma not to receive the vaccination, although one should always discuss this with his or her health professional.

The CDC offers a helpful fact sheet regarding herpes zoster virus.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap